Elos Medtech Bilanço Sağlığı
Finansal Sağlık kriter kontrolleri 6/6
Elos Medtech has a total shareholder equity of SEK788.2M and total debt of SEK407.1M, which brings its debt-to-equity ratio to 51.6%. Its total assets and total liabilities are SEK1.6B and SEK772.0M respectively. Elos Medtech's EBIT is SEK136.9M making its interest coverage ratio 3.2. It has cash and short-term investments of SEK117.3M.
Anahtar bilgiler
51.6%
Borç/özkaynak oranı
SEK 407.10m
Borç
| Faiz karşılama oranı | 3.2x |
| Nakit | SEK 117.30m |
| Eşitlik | SEK 788.20m |
| Toplam yükümlülükler | SEK 772.00m |
| Toplam varlıklar | SEK 1.56b |
Son finansal sağlık güncellemeleri
We Think Elos Medtech (STO:ELOS B) Is Taking Some Risk With Its Debt
Mar 24
Elos Medtech (STO:ELOS B) Has A Somewhat Strained Balance Sheet
Dec 13
Recent updates
Calculating The Fair Value Of Elos Medtech AB (publ) (STO:ELOS B)
Oct 11Is Now The Time To Look At Buying Elos Medtech AB (publ) (STO:ELOS B)?
May 23Here's Why I Think Elos Medtech (STO:ELOS B) Is An Interesting Stock
May 10Returns On Capital Are Showing Encouraging Signs At Elos Medtech (STO:ELOS B)
Apr 17We Think Elos Medtech (STO:ELOS B) Is Taking Some Risk With Its Debt
Mar 24Should Elos Medtech AB (publ) (STO:ELOS B) Be Part Of Your Dividend Portfolio?
Mar 11The President & CEO of Elos Medtech AB (publ) (STO:ELOS B), Jan Wahlström, Just Bought 28% More Shares
Feb 28Do Fundamentals Have Any Role To Play In Driving Elos Medtech AB (publ)'s (STO:ELOS B) Stock Up Recently?
Feb 24Elos Medtech (STO:ELOS B) Has Gifted Shareholders With A Fantastic 102% Total Return On Their Investment
Feb 11When Should You Buy Elos Medtech AB (publ) (STO:ELOS B)?
Jan 31How Much Are Elos Medtech AB (publ) (STO:ELOS B) Insiders Taking Off The Table?
Jan 18Returns On Capital At Elos Medtech (STO:ELOS B) Paint An Interesting Picture
Jan 06Could The Elos Medtech AB (publ) (STO:ELOS B) Ownership Structure Tell Us Something Useful?
Dec 26Elos Medtech (STO:ELOS B) Has A Somewhat Strained Balance Sheet
Dec 13Here's Why We Don't Think Elos Medtech's (STO:ELOS B) Statutory Earnings Reflect Its Underlying Earnings Potential
Nov 30Elos Medtech AB (publ)'s (STO:ELOS B) Stock On An Uptrend: Could Fundamentals Be Driving The Momentum?
Nov 17Finansal Durum Analizi
Kısa Vadeli Yükümlülükler: ELOS B's short term assets (SEK577.9M) exceed its short term liabilities (SEK289.8M).
Uzun Vadeli Yükümlülükler: ELOS B's short term assets (SEK577.9M) exceed its long term liabilities (SEK482.2M).
Borç-Özkaynak Tarihçesi ve Analizi
Borç Seviyesi: ELOS B's net debt to equity ratio (36.8%) is considered satisfactory.
Borcun Azaltılması: ELOS B's debt to equity ratio has reduced from 57.1% to 51.6% over the past 5 years.
Borç Kapsamı: ELOS B's debt is well covered by operating cash flow (23.4%).
Faiz Kapsamı: ELOS B's interest payments on its debt are well covered by EBIT (3.2x coverage).